A Giant, Complex Fibroepithelial Tumor of the Breast: Borderline Phyllodes Tumor Combined with Tubular Adenoma - a Rare Clinical Presentation of a Fibroepithelial Tumor of the Breast
| Author | Ibisevic, Nermina |
| Author | Bajrovic, Jasmina |
| Author | Saranovic, Ena |
| Author | Spiritovic, Dijana |
| Author | Skenderi, Faruk |
| Author | Vranic, Semir |
| Available date | 2021-06-14T08:11:48Z |
| Publication Date | 2021-04-01 |
| Publication Name | Acta medica academica |
| Identifier | http://dx.doi.org/10.5644/ama2006-124.337 |
| Citation | Ibisevic N, Bajrovic J, Saranovic E, Spiritovic D, Skenderi F, Vranic S. A Giant, Complex Fibroepithelial Tumor of the Breast: Borderline Phyllodes Tumor Combined with Tubular Adenoma - a Rare Clinical Presentation of a Fibroepithelial Tumor of the Breast. Acta Med Acad. 2021 Apr;50(1):218-220. doi: 10.5644/ama2006-124.337. |
| ISSN | 1840-1848 |
| Abstract | * |
| Language | en |
| Publisher | NLM (Medline) |
| Subject | Breast Fibroepithelial Tumors Phyllodes Tumor Tubular Adenoma |
| Type | Article |
| Pagination | 218-220 |
| Issue Number | 1 |
| Volume Number | 50 |
| ESSN | 1840-2879 |
Files in this item
This item appears in the following Collection(s)
-
Medicine Research [1548 items ]
Related items
Showing items related by title, author, creator and subject.
-
Magnetic mesoporous nanospheres anchored with LyP-1 as an efficient pancreatic cancer probe
( Elsevier Ltd , 2017 , Article)Immobilization of a ligand that selectively interacts with cancer cells to nanomaterials can enhance their diagnostic and therapeutic efficiency. In this study, we firstly demonstrate the high expression of receptor for ... -
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
( BMC , 2022 , Article Review)Over the past decade, invasive techniques for diagnosing and monitoring cancers are slowly being replaced by non-invasive methods such as liquid biopsy. Liquid biopsies have drastically revolutionized the field of clinical ... -
The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
(2021 , Article)Nanomedicine has emerged as a novel cancer treatment and diagnostic modality, whose design constantly evolves towards increasing the safety and efficacy of the chemotherapeutic and diagnostic protocols. Molecular diagnostics, ...
